A long-acting GLP-1 receptor agonist that mimics the incretin hormone glucagon-like peptide-1. It binds to GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and strongly activate central satiety centers in the brain. This results in effective appetite suppression, improved blood sugar control, and substantial, sustained fat loss.
